Nevoit, Mintser, Potyazhenko and Vainoras; and Barassi and colleagues (2026), in Advances in Bioelectromagnetism, Elsevier. Two narrative book chapters by proponents on proposed mechanisms. Not primary data. Confirmed through Crossref only; chapters not read.
Category Archives: Independent
Carried out by a university, hospital or research institute with no commercial link to a bioresonance device manufacturer, and published outside the bioresonance community.
Bobrytska and colleagues (2019), Scientific Horizons, Zhytomyr. Diagnostic comparison against blood chemistry in 35 dogs. Reports 91.4 per cent agreement with laboratory liver markers. Citation confirmed through DOAJ only.
Bobrytska, Ugai and colleagues (2018), Scientific Horizons, Zhytomyr, Ukrainian. Diagnostic study with a Parkes-D device. Reports agreement between bioresonance testing and laboratory findings. Sample not verified; citation confirmed through Crossref only.
Fyk and colleagues (2025), Ukrainian Journal of Military Medicine. Described as a prospective randomised trial, 135 patients. Reports pain, sleep, CRP and IgG changes with a Ukrainian multiphysics device, not a BICOM or MORA system. Citation verified through Crossref only.
Barassi, Pokorski, Pellegrino and colleagues (2022), Advances in Experimental Medicine and Biology. Clinical observational study with an ion cyclotron resonance device; sample not stated in the abstract. Reports pain reduction. Cited by the group’s 2024 Medicina paper as its mechanism basis.
Erdoğan and colleagues (2025), İstanbul Rumeli University Journal of Health Sciences. Before and after, uncontrolled, seven dogs. Reports a 2.8 per cent rise in a device-derived spleen index only; other indices unchanged. The measures come from the same quantum pet analysis device.
Farsijani, Safi and Shirazi Beheshtiha (2023), Archives of Razi Institute. Diagnostic comparison in 30 cats. Reports 100 per cent sensitivity and 81.8 per cent specificity for the specific modulation frequency test. The reference standard included the index test itself, which is a design flaw.
Krzysztof, Strus and Nabagło (2020), Research Square preprint. In vitro test on bacterial and fungal strains. Reports no significant reduction in pathogen counts compared with controls. Not peer reviewed.
Cosentino and colleagues, University of Insubria (2026), bioRxiv preprint. In vitro, blinded, active device against a mock device, cell cultures. Reports the active QDOME device reduced hydrogen peroxide induced cell death. Not yet peer reviewed.
Cabıoğlu and colleagues (2022), Bulletin of Experimental Biology and Medicine. Animal study, chronic mild stress model in mice. Reports shorter immobility in forced swim and tail suspension tests after longer bioresonance exposure. The authors call for replication.